Comparison

Pyroxamide

Item no. CS-0003180-10mg
Manufacturer ChemScene
Amount 10mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 382180-17-8
Similar products 382180-17-8
Available
CAS
382180-17-8
Purity
>98%
MWt
265.31
Formula
C13H19N3O3
Solubility
DMSO : 125 mg/mL (471.15 mM; Need ultrasonic)
Clinical Information
Phase 1
Pathway
Epigenetics; Cell Cycle/DNA Damage
Target
HDAC; HDAC
Biological Activity
Pyroxamide is a potent inhibitor of histone deacetylase 1 (HDAC1) with an ID50 of 100 nM. Pyroxamide can induce apoptosis and cell cycle arrest in leukemia. IC50 & Target: ID50: 100 nM[1] In Vitro: Pyroxamide (1.25-20.0 uM; 24-72 hours) suppresses RD and RH30B cells growth, pyroxamide resulted in 44% dead cells for 72 h at 20.0 uM, results in 86% dead cells in culture[1].
Pyroxamide (10.0-20.0 uM; 48 hours) shows sub-G1 fractions of 45.0% and 72.3% at 10.0 and 20.0 uM, respectively[1].
Research Area
Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close